Healthcare Investors / Advisors

US to Prioritize Private Equity’s Role in Healthcare Fraud

The Justice Department is focusing on private equity’s role in causing healthcare fraud, the head of the Civil Division said Thursday. “We have already had a few cases involving private equity firms, and given the significant role that private equity is increasingly playing in the healthcare field, we anticipate that their impact on healthcare billings

US to Prioritize Private Equity’s Role in Healthcare Fraud Read More »

Money Talks: Private Equity Has a Growing Interest in Otolaryngology

Private equity investment in healthcare increased almost three-fold between 2010 and 2019, from $41.5 billion to $119.9 billion, according to a report by the American Antitrust Center, Petris Center, and Washington Center for Equitable Growth. And while private equities’ initial investments in healthcare were in orthopedics, ophthalmology, and dermatology, interest in otolaryngology has been increasing.

Money Talks: Private Equity Has a Growing Interest in Otolaryngology Read More »

Q4 2023 Update: Private Equity Deals in Medical Devices in North America

In the North American medical devices industry, there were 12 private equity deals announced in Q4 2023, worth a total value of $1.1bn, according to GlobalData’s Deals Database. The $635.4m Institutional Buy-out (IBO) Sharecare by Claritas Capital was the industry’s largest disclosed deal. In value terms, private equity deal activity in North America decreased by

Q4 2023 Update: Private Equity Deals in Medical Devices in North America Read More »

Behavioral Health Providers Could Turn to Foreign Investors for Next Capital Infusion

As the domestic capital market for behavioral health companies tightens, foreign investment presents a timely new financing opportunity. Specifically, the EB-5 investment visa program, which incentivizes foreign investors to pour capital into American businesses, could be a new avenue for providers. High-interest rates and high-profile stumbles in the behavioral health space have significantly slowed investment

Behavioral Health Providers Could Turn to Foreign Investors for Next Capital Infusion Read More »

Q4 2023 Update: Private Equity Deals in the Pharmaceutical Industry in the US

In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of $700.5m, according to GlobalData’s Deals Database. The $375m management buy-in (mbi) ZimVie by H.I.G. Capital was the industry’s largest disclosed deal. In value terms, private equity deal activity in the US decreased by 84% in

Q4 2023 Update: Private Equity Deals in the Pharmaceutical Industry in the US Read More »

Scroll to Top